Description
GDC-0623 is an inhibitor of MEK that prevents MEK-dependent B-Raf and KRAS signaling. GDC-0623 exhibits anticancer chemotherapeutic activity and is currently in clinical trials as a potential treatment for several cancers.
Product Unit Size | Cost | Quantity | Stock |
---|
GDC-0623 is an inhibitor of MEK that prevents MEK-dependent B-Raf and KRAS signaling. GDC-0623 exhibits anticancer chemotherapeutic activity and is currently in clinical trials as a potential treatment for several cancers.
Cas No. | 1168091-68-6 |
---|---|
Purity | ≥98% |
Formula | C16H14FIN4O3 |
Formula Wt. | 456.21 |
IUPAC Name | 5-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)imidazo[1,5-a]pyridine-6-carboxamide |
Solubility | DMSO 91 mg/mL warmed (199.46 mM) Ethanol 5 mg/mL warmed (10.95 mM) Water Insoluble |
Appearance | Beige Powder |
Store Temp | 4°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Hatzivassiliou G, Haling JR, Chen H, et al. Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers. Nature. 2013 Sep 12;501(7466):232-6. PMID: 23934108.
Nucleoside (deoxycytidine) analog; ribonucleoti...
Tyrphostin; VEGFR inhibitor.
EZH2 HMT inhibitor.
NSAID; TREK1 K+ potentiator, voltage-gated Na+ ...
R,R enantiomer of formoterol; β2-adrenergic an...
COVID-19 research
Imidazoquinazoline; PDE3 inhibitor.
Endogenous opioid peptide; μOr agonist.
GABA-A agonist.
Dual kinase and GTPase inhibitor.
NSAID; COX inhibitor and HS-releasing agent.
Coccidiostat.
Captothecin derivative; topoisomerase I inhibit...
Diacerein metabolite, anthraquinone found in Rh...
Found in Paeonia, Arisaema, Dioscorea; MAO-A/B ...
Purine nucleoside analog; DNA chain terminator,...
SERM.
Promotes degradation of cIAP1
Phenol found in Zingiber; 5-HT3 antagonist.